Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
  • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
  • A61K31/445—Non condensed piperidines, e.g. piperocaine
  • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
  • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
  • A61K31/5375—1,4-Oxazines, e.g. morpholine
  • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P3/00—Drugs for disorders of the metabolism
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P3/00—Drugs for disorders of the metabolism
  • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
  • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
  • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
  • C07C215/40—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton with quaternised nitrogen atoms bound to carbon atoms of the carbon skeleton
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
  • C07C53/02—Formic acid
  • C07C53/06—Salts thereof
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
  • C07C53/08—Acetic acid
  • C07C53/10—Salts thereof
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
  • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
  • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
  • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
  • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
  • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
  • C07D471/04—Ortho-condensed systems
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
  • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
  • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• General Health & Medical Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Life Sciences & Earth Sciences (AREA)
• Medicinal Chemistry (AREA)
• Diabetes (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Epidemiology (AREA)
• Engineering & Computer Science (AREA)
• Obesity (AREA)
• Hematology (AREA)
• Emergency Medicine (AREA)
• Endocrinology (AREA)
• Cardiology (AREA)
• Heart & Thoracic Surgery (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Plural Heterocyclic Compounds (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Nitrogen Condensed Heterocyclic Rings (AREA)
• Peptides Or Proteins (AREA)

Applications Claiming Priority (4)

Publications (1)

Family

ID=67003576

Family Applications (1)

Country Status (38)

Families Citing this family (60)

Family Cites Families (28)

• 2019
  • 2019-06-10 CA CA3045644A patent/CA3045644C/en active Active
  • 2019-06-10 TW TW108119890A patent/TWI707683B/en active
  • 2019-06-10 US US16/436,311 patent/US10934279B2/en active Active
  • 2019-06-11 FI FIEP19733151.5T patent/FI3806955T3/en active
  • 2019-06-11 SG SG11202011465QA patent/SG11202011465QA/en unknown
  • 2019-06-11 BR BR112020024470-8A patent/BR112020024470A2/en unknown
  • 2019-06-11 CN CN201980053632.5A patent/CN112533674A/en active Pending
  • 2019-06-11 PE PE2020001993A patent/PE20211601A1/en unknown
  • 2019-06-11 KR KR1020217000940A patent/KR102542199B1/en active IP Right Grant
  • 2019-06-11 MD MDE20210363T patent/MD3806955T3/en unknown
  • 2019-06-11 HR HRP20230631TT patent/HRP20230631T1/en unknown
  • 2019-06-11 CU CU2020000099A patent/CU20200099A7/en unknown
  • 2019-06-11 NZ NZ770240A patent/NZ770240A/en unknown
  • 2019-06-11 AU AU2019285491A patent/AU2019285491B2/en active Active
  • 2019-06-11 UA UAA202007608A patent/UA124371C2/en unknown
  • 2019-06-11 MX MX2020013625A patent/MX2020013625A/en unknown
  • 2019-06-11 CR CR20200612A patent/CR20200612A/en unknown
  • 2019-06-11 EP EP23155747.1A patent/EP4219487A1/en active Pending
  • 2019-06-11 ES ES19733151T patent/ES2949954T3/en active Active
  • 2019-06-11 IL IL279300A patent/IL279300B2/en unknown
  • 2019-06-11 SI SI201930570T patent/SI3806955T1/en unknown
  • 2019-06-11 GE GEAP201915517A patent/GEP20237453B/en unknown
  • 2019-06-11 JP JP2020569190A patent/JP6916968B1/en active Active
  • 2019-06-11 HU HUE19733151A patent/HUE063074T2/en unknown
  • 2019-06-11 PT PT197331515T patent/PT3806955T/en unknown
  • 2019-06-11 EP EP19733151.5A patent/EP3806955B9/en active Active
  • 2019-06-11 WO PCT/IB2019/054867 patent/WO2019239319A1/en unknown
  • 2019-06-11 DK DK19733151.5T patent/DK3806955T3/en active
  • 2019-06-11 RS RS20230504A patent/RS64323B9/en unknown
  • 2019-06-11 LT LTEPPCT/IB2019/054867T patent/LT3806955T/en unknown
  • 2019-06-11 PL PL19733151.5T patent/PL3806955T3/en unknown
  • 2019-06-11 PE PE2023003553A patent/PE20240584A1/en unknown
  • 2019-06-12 UY UY0001038261A patent/UY38261A/en unknown
  • 2019-08-08 US US16/535,616 patent/US10676465B2/en active Active
  • 2019-08-08 US US16/535,553 patent/US10683281B2/en active Active
• 2020
  • 2020-12-01 NI NI202000091A patent/NI202000091A/en unknown
  • 2020-12-02 PH PH12020552069A patent/PH12020552069A1/en unknown
  • 2020-12-04 ZA ZA2020/07572A patent/ZA202007572B/en unknown
  • 2020-12-04 EC ECSENADI202078651A patent/ECSP20078651A/en unknown
  • 2020-12-07 CO CONC2020/0015305A patent/CO2020015305A2/en unknown
  • 2020-12-11 CL CL2020003222A patent/CL2020003222A1/en unknown
• 2021
  • 2021-02-09 US US17/171,385 patent/US20210163455A1/en not_active Abandoned
• 2023
  • 2023-07-19 CY CY20231100347T patent/CY1126097T1/en unknown
  • 2023-10-09 US US18/483,311 patent/US20240059679A1/en active Pending

Also Published As

Similar Documents